Storage and Use of Newborn Screening Blood Spot Cards New Requirements June 1, 2012

Similar documents
Leveraging the Attention

MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH POLICY ON THE RETENTION, STORAGE, AND USE OF NEWBORN SCREENING DATA AND RESIDUAL SPECIMENS DECEMBER 2015

Preparing Birthing Hospitals to Implement Parental Consent for the Michigan BioTrust for Health Challenges and Successes One Year Later

Massachusetts Newborn Screening Public Health Service, Research and. Public Trust

Research and Survey Application Manual

Pertussis, Strep Throat testing & Resources. Michelle Anguiano C.A.R.E. Unit Manager

California Newborn Screening Program Update

APPLICATION FOR RESEARCH REQUESTING AN IRB WAIVER OF CONSENT AND HIPAA AUTHORIZATION

Newborn Genetic Testing & Surveillance System

Translational Research in Newborn Screening: Development of a Virtual Repository of Residual Dried Blood Spots

HIPAA Privacy Regulations Governing Research

Newborn Genetic Testing & Surveillance System

Grambling State University Application for Human Subjects Review IRB Protocol. 1. Principal Investigator [Last Name, First Name, Middle Initial]

MEDICAL POWER OF ATTORNEY

New HIPAA Privacy Regulations Governing Research. Karen Blackwell, MS Director, HIPAA Compliance

The Queen s Medical Center HIPAA Training Packet for Researchers

JUST THE FAX NOTIFICATION: CALIFORNIA PRENATAL SCREENING PROGRAM

Study Initiation Meeting

Scripps Clinic Medical Group (SCMG) and SCRIPPS HEALTH INFORMED CONSENT STATEMENT FOR. Study Title: SCMG & Scripps Health Bio-Repository

The Children's Clinic Patient Information Form

Disclosure Statement for Medical Power of Attorney

HIPAA COMPLIANCE APPLICATION

Parkland Health & Hospital System Department of Pathology Research Support

UCLA Newborn Screening Symposium 2018

Compliance Policy C-FMS Clinical Research Project Approval Application

SCREENING PROCEDURES: WHAT IS COVERED BY A

Study Start-Up SS STANDARD OPERATING PROCEDURE FOR PRE-STUDY SITE VISIT (PSSV)

To provide an integrated and coordinated approach to delivering Newborn Metabolic Screening (NMS) Program services to all infants born in Alberta.

Printed from the Texas Medical Association Web site.

BIMO SITE AUDIT CHECKLIST

Williamson County & Cities Health District Epidemiologist I Foodborne Disease Epidemiologist

Institutional Review Board Student (Other Investigator) Instructions & Information. Do not begin work until written IRB approval is issued!

MEDICAL POWER OF ATTORNEY DESIGNATION OF HEALTH CARE AGENT.

Laboratory System Improvement Program (L SIP)

If you require films or CD, kindly give us 48 hour notice or make technologist aware at the time of your study.

Family Cord Blood and Cord Tissue Banking Enrollment Documents Services Agreement

HIPAA & Research Overview for the Privacy Board March 22, UAMS HIPAA Office Vera M. Chenault, JD

Use And Disclosure Of Protected Health Information (PHI) For Research

JUST THE FAX NOTIFICATION: CALIFORNIA PRENATAL SCREENING PROGRAM

Consent Form Requirements for Multicenter studies when CHOP Relies on an external IRB

Administration Manual Insulin Pump Program (IPP) Policies and Procedures Version 3.0

INFORMED CONSENT TO PARTICIPATE IN A DIABETES RESEARCH REGISTRY

ELIGIBILITY SERVICES DEPARTMENTAL GUIDELINES AND PROCEDURES TITLE: COMMUNICATION TO PATIENT REGARDING FINANCIAL ASSISTANCE DETERMINATION

TEHDI CONTINUUM OF CARE FOR AUDIOLOGISTS

Record or Document Type Retention Period Relevant Legal Citation(s) IRB Records: Training Records;

LifeBridge Health HIPAA Policy 4. Uses of Protected Health Information for Research

Advance Directive Form

Oklahoma Health Care Authority (OHCA) Pharmacy Provider Attestation Hemophilia and Other Rare Bleeding Disorders Standards of Care

Patient Instructions to Obtain Copies of Medical Records

Inventory of Biological Specimens, Registries, and Health Data and Databases REPORT TO THE LEGISLATURE

Common Pitfalls to the Non-Course-Based Research IRB Application. Revised December, 2013

Staff Training. Understanding Healthix Patient Consent

CLOSE OUT VISIT REPORT (NO CRF TO MONITOR)

Initially Submitted on 11/24/2009 Final Submission By Test6 CA on 11/24/2009 1:51 PM Approval By student13 student13 on 11/24/2009 1:52 PM Attendees

AN ACT. SECTION 1. Title 4, Civil Practice and Remedies Code, is amended by CHAPTER 74A. LIMITATION OF LIABILITY RELATING TO HEALTH INFORMATION

Preparing for Audits and Post Approval Monitoring April 29, 2015

Medical Power of Attorney Designation of Health Care Agent 2 Witnesses. I, (insert your name) appoint: Name: Address:

UNIVERSITY MEDICAL CENTER NEW ORLEANS RESEARCH REVIEW APPLICATION

POLICY AND REGULATIONS MANUAL TITLE: HOSPITALIZATION & MEDICAL NECESSITY REVIEW

PCMH 2014 Recognition Checklist

PURDUE UNIVERSITY WEST LAFAYETTE, INDIANA SCHOOL OF NURSING STUDENT DRUG TESTING POLICY PRIOR TO PARTICIPATION IN CLINICAL ACTIVITIES

OPEN Person Types and Business Rules Revision 2

Karen W. Dyer MT(ASCP), DLM Director, Division of Laboratory Services Centers for Medicare & Medicaid Services CLIA

PATIENT INFORMATION. In Case of Emergency Notification

December 2015 Research Administration Working Group WELCOME OFFICE OF THE VICE PRESIDENT FOR RESEARCH

Health organizations integrate variety of clinical information and administrative types of information systems. These systems collect, process, and

10 STEPS TO IRB APPROVAL

General Procedure - Institutional Review Board

THIS IS AN IMPORTANT LEGAL DOCUMENT. BEFORE SIGNING THIS DOCUMENT, YOU SHOULD KNOW THESE IMPORTANT FACTS:

System of Records Notice (SORN) Checklist

Effective Date: November 12, 2015 Policy Number: MHC_RP0306. Corporate Director, HRPP Institutional Official, HRPP

Sterilization Consent Form Instructions

Transportation Advisory Board Regional Program Year Policy

Patient Section. Patient Name: (Last) (First) (MI) Address: City: State: Zip: Date of Birth: / / Month Day Year Home Phone: ( ) - Cell Phone: ( ) -

Sample. A guide to development of a hospital blood transfusion Policy at the hospital level. Effective from April Hospital Transfusion Committee

Transfusion Safety in Practice. Ana Lima Transfusion Safety Nurse Sunnybrook Health Sciences Centre Toronto, Ontario CANADA

Newborn bloodspot screening

Objectives. With the completion of this module the learner will:

Navigating HIPAA Regulations. Michelle C. Stickler, DEd Director, Research Subjects Protections

Provider Portal Hints & Tips Frequently Asked Questions

PRIVACY POLICY 18/8/2016

Regulatory Binder Checklist for FDA-Regulated Sponsor/Sponsor-Investigator Studies

If you would like your child to participate in the Life Health Center School Wellness Program, please complete pages 1-5.

MACOMB COUNTY COMMUNITY MENTAL HEALTH ACKNOWLEDGMENT AND CONSENT FORM

LIBERTY DENTAL PLAN. Dental Hygienist - Credentialing Application. City: State: DEGREE: City: State: DEGREE:

REGISTERING A PATIENT

Office of Mental Health Continuous Quality Improvement Initiative for Health Promotion and Care Coordination: 2013 Project Activities and

UA New Common Rule Implementation

Self-Monitoring Tool

Patient Privacy Requirements Beyond HIPAA

Authorization and Waiver Frequently Asked Questions

Telemedicine Privacy and Security: Safeguarding Protected Health Information and Minimizing Risks of Disclosure

Module: Research and HIPAA Privacy Protections ( )

Advanced Directive For Health Care

SARASOTA MEMORIAL HOSPITAL

Inpatient orders and Physician Certification MUST BE authenticated PRIOR to discharge No EXCEPTIONS.

QUALITY ASSURANCE PROGRAM

EXHIBITOR & SPONSOR PROSPECTUS

The Privacy & Security of Protected Health Information

TELNET COURSE T2861 PART 1 (WEBINAR) TELNET COURSE T2864 PART 2 (WEBINAR) TELNET COURSE T2866 PART 3 (WEBINAR) DATE: SEPTEMBER 26, 2013

Transcription:

Storage and Use of Newborn Screening Blood Spot Cards New Requirements June 1, 2012

HB 1672 and HB 411 Page 2

Agenda History HB 1672, HB 411 Comparison of Requirements under Different Laws New Forms for HB 411 starting June 1, 2012 New Healthcare Provider Responsibilities for HB 411 Logistics of Transition HB 411 Points of Contact / Resources Page 3

History of Blood Spot Storage and Use Laws May 2009 - HB 1672 Outlined allowable uses of residual blood spots Required healthcare providers to give a form to the parents when the newborn screen was collected Information about the uses of the blood spots Parental request for destruction of the blood spots Page 4

History of Blood Spot Storage and Use Laws May 2011 - HB 411 Effective June 2011 - Strengthens the DSHS management review and approval processes of proposed post-screening uses Effective June 1, 2012 - Requires parental consent for: Storage longer than 2 years External public health research uses New Decision Form Page 5

Comparison of Timeframe Requirements Storage of Residual Blood Spots Allowed Uses Internal DSHS External Research Parent Options May 27, 2009 HB 1672 June 1, 2012 HB 411 Page 6

Blood Spot Storage Length of Storage after Completion of the Newborn Screen Test Prior to May 27, 2009 Up to 25 years Destroyed in February 2010 per legal settlement May 27, 2009 through May 2012 (HB 1672) To be determined Page 7 Beginning June 1, 2012 (HB411) All blood spots are stored for up to 2 years and then destroyed unless the parent submits a completed decision form allowing for longer storage.

Protection of Patient Privacy IMPORTANT: No information that identifies the child or parent can be released outside DSHS without specific written OK from the parent Specimens are stored safely and securely Page 8

Allowed DSHS Uses Allowed uses include: Quality assurance to make sure lab tests, equipment, and supplies are working right Developing new tests; and/or DSHS studies of diseases that affect public health. Page 9

Public Health Research Use outside of DSHS During all timeframes: DSHS IRB and management approval required De-identified blood spots only May 27, 2009 through May 2012 June 1, 2012 or Later Not allowed without study specific parental consent. Allowed only if parent provides written consent (decision form). Uses must follow DSHS policy for required management and IRB approvals. Page 10

Parent Options May 27, 2009 through May 2012 HB 1672 June 1, 2012 or Later HB 411 Parents may direct DSHS to destroy their child s blood spots within 60 days Parents may choose to have the blood spots stored for up to 25 years and to possibly be used for de-identified public health research uses outside of DSHS. Page 11

New Forms June 1, 2012 New Forms for HB 411 Page 12

New Forms June 1, 2012 HB 411 requires the distribution of 2 new forms to parents upon collection of each newborn screen Effective date: June 1, 2012 Explains parent options Gives parents a means to allow or refuse longterm storage and use of specimens Replaces requirement to distribute current Parent Copy and Disclosure / Directive to Destroy forms Page 13

New Forms June 1, 2012 Goals of Form Development Team Ensure parents understand their choices Ensure compliance with parental choices Streamline healthcare provider distribution Ensure compliance with law Streamline DSHS processing Ensure enough information is requested on forms to match forms to specimens Maximize parent / patient privacy Improve general Newborn Screening education Page 14

New Forms June 1, 2012 Development Summary 22 draft versions Developed with input from: Professional medical organizations including TMA, TPS, and THA Parents Submitting facility physicians, nurses, and technologists DSHS Laboratory and Clinical Care Coordination staff Legal advisors Reviewed by DSHS Executive Leadership Texas Legislative Offices Healthcare Provider Stakeholders Page 15

Parent Information Form Page 1 of 2012 Kits (Replaces Page 1 of previous kits) English / Spanish Front / Back Distribute to parent upon collection of each specimen Parents should take form received at collection of first screen to their baby s doctor when the baby is 7 to 14 days of age Will be OK to still distribute older version beginning June 1. Medicaid / CHIP / Charity Page 16 Insurance / Self-Pay

Parent Information Form Parent instructions to take form received at 1 st screen to doctor when baby is 7 to 14 days of age Information about residual specimen storage / use and Parental Decision form (Page 2) Expanded and simplified general newborn screening information Page 17 Contact phone number and web address

Parental Decision for Storage and Use of NBS Blood Spot Cards Page 2 of 2012 Kits (Replaces Page 2 of previous kits) English / Spanish Front / Back (Vietnamese online) By law, starting June 1, 2012, MUST be distributed to parent upon collection of each specimen Intent is that all parents make a decision one way or the other Parents may: Complete form and return to healthcare provider to be shipped with any regular newborn screening specimen shipment; OR Mail in at a later date Page 18

Parental Decision for Storage and Use of NBS Blood Spot Cards Explanation of Choices Forms without a signature or a selection will default to No Parents only need to complete form once per child Signature is required to process OK selection Page 19

New Healthcare Provider Responsibilities for HB 411 Page 20

Healthcare Provider Responsibilities Step 1: Distribute to parents upon collection of each newborn screening specimen. Texas Newborn Screening Parent Information (Page 1 of 2012 Kits) and Parental Decision for Storage and Use of Newborn Screening Blood Spot Cards (Decision form) (Page 2 of 2012 Kits) Page 21

Healthcare Provider Responsibilities STEP 2: Advise parents that they should : Read Page 1 Texas Newborn Screening Parent Information. Take the form given to them upon collection of the first screen to their child s healthcare provider when the child is 7 to 14 days of age. Read Page 2, Parental Decision for Storage and Use of Newborn Screening Blood Spot Cards, select an option, and return to DSHS. Parents may return the form to the healthcare provider at the time of collection or mail it into DSHS at a later date. Page 22

Healthcare Provider Responsibilities STEP 3: Check the box on the demographic form (Page 3) that the Use and Storage form was given to the parent. STEP 4: If requested by parent, return the completed form to DSHS along with any regular newborn screening specimen shipment Page 23

Older Collection Kits What do Healthcare Providers do with the older collection kits (2010 and 2011) starting on June 1, 2012? Continue to use the 2010 and 2011 collection kits through the kit expiration date. Page 24 8 ½ X 11 form is available at: http://www.dshs.state.tx.us/lab/nbsbloodspots.shtm

Educational Resources Official notification letter Monthly NBS listserv updates Kit order inserts Website updates http://www.dshs.state.tx.us/lab/nbsbloodspots.htm Webinars CE modules Video Pamphlets / flyers Page 25

Resources Web http://www.dshs.state.tx.us/lab/nbsbloodspots.shtm Phone: 1-888-963-7111, ext. 7333, or 512-776-7333 Email: NewbornScreeningLab@dshs.state.tx.us Page 26